Intriguingly, MCR activation in APP/PS1 mice led to the drastic reduction of the neurotoxic A1 subtype of reactive astrocytes, which is the major astrocytic subtype that mediates astrocytic toxicity in AD. The gene discussed is NR3C2; the disease is Alzheimer disease.